SARS-CoV-2 Is Persistent in Placenta and Causes Macroscopic, Histopathological, and Ultrastructural Changes

Viruses. 2022 Aug 26;14(9):1885. doi: 10.3390/v14091885.

Abstract

SARS-CoV-2 is a virus that belongs to the Betacoronavirus genus of the Coronaviridae family. Other coronaviruses, such as SARS-CoV and MERS-CoV, were associated with complications in pregnant women. Therefore, this study aimed to report the clinical history of five pregnant women infected with SARS-CoV-2 (four symptomatic and one asymptomatic who gave birth to a stillborn child) during the COVID-19 pandemic. They gave birth between August 2020 to January 2021, a period in which there was still no vaccination for COVID-19 in Brazil. In addition, their placental alterations were later investigated, focusing on macroscopic, histopathological, and ultrastructural aspects compared to a prepandemic sample. Three of five placentas presented SARS-CoV-2 RNA detected by RT-PCRq at least two to twenty weeks after primary pregnancy infection symptoms, and SARS-CoV-2 spike protein was detected in all placentas by immunoperoxidase assay. The macroscopic evaluation of the placentas presented congested vascular trunks, massive deposition of fibrin, areas of infarctions, and calcifications. Histopathological analysis showed fibrin deposition, inflammatory infiltrate, necrosis, and blood vessel thrombosis. Ultrastructural aspects of the infected placentas showed a similar pattern of alterations between the samples, with predominant characteristics of apoptosis and detection of virus-like particles. These findings contribute to a better understanding of the consequences of SARS-CoV-2 infection in placental tissue, vertical transmission.

Keywords: COVID-19; inflammation; pathogenesis; pregnant women; viral particles.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Female
  • Fibrin
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Pandemics
  • Placenta
  • Pregnancy
  • Pregnancy Complications, Infectious*
  • RNA, Viral
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Substances

  • RNA, Viral
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Fibrin

Grants and funding

This research was funded by Oswaldo Cruz Institute—Fiocruz and Rio de Janeiro State University. This study was partially supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES-Finance Code 001.